The Effect of Prucalopride Succinate on Gastrointestinal Motility After Laparoscopic Gastrectomy : Prospective Double Blind Case-control Study
Gastric Cancer
About this trial
This is an interventional treatment trial for Gastric Cancer
Eligibility Criteria
Inclusion Criteria: Patients diagnosed with gastric adenocarcinoma pathologically before surgery Patients who underwent complete surgical resection (R0 resection) Patients with an ASA score of 3 or less Exclusion Criteria: Patients over 80 years of age Ascites or peritoneal metastasis If you have intestinal obstruction before surgery If chemotherapy was performed before surgery If cancer other than gastric cancer is diagnosed If there is a history of previous major intra-abdominal long-term surgery or abdominal radiation therapy In case of liver failure or renal failure Pregnant women If it is judged that uncontrolled diabetes can affect intestinal function If you have a stoma
Sites / Locations
- GangnamSeverance Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Prucalopride succinate group
Control (mosapride citrate) group
Taking prucalopride succinate from the first day to the fifth day after surgery.
Taking mosapride citrate from the first day to the fifth day after surgery.